财务
- Market Capitalization 1.74 B
- Employee 260
- Founded 1997
- CEO N/A
- Website www.xencor.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG4W0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-12.35
市销率
9.05
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1991 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 9.78 USD | -4.12% | -3.26% | +29.19% | +20.15% | 1.78 B USD | ||
| 1996 | URGN UroGen Pharma Ltd. - Ordinary Shares | 36.60 USD | -4.34% | -10.07% | -15.38% | +92.63% | 1.79 B USD | ||
| 2011 | MESO Mesoblast Limited - American Depositary Shares | 13.78 USD | -0.86% | -1.15% | -6.89% | -22.58% | 1.79 B USD | ||
| 2013 | VIR Vir Biotechnology, Inc. - Common Stock | 10.43 USD | -1.70% | -9.46% | -2.61% | +74.41% | 1.76 B USD |